| In EUR m | Q3 2023 | Q3 2022 | 9M 2023 | 9M 2022 |
| Revenue | 483.6 | 436.3 | 1,348.3 | 1,246.3 |
| EBITDA (adjusted) | 147.5 | 133.6 | 374.6 | 353.9 |
| Exceptional items | 0.3 | -2.7 | -4.0 | 5.4 |
| EBITDA | 147.7 | 130.9 | 370.7 | 359.3 |
| Amortization, depreciation and impairment | -78.6 | -73.3 | -231.2 | -219.6 |
| thereof attributable to purchase price allocations and impairment losses |
| EBIT | -4.5 | -6.8 | -14.3 | -20.3 |
| Net finance income/costs | 69.2 | 57.6 | 139.4 | 139.7 |
| EBT | -19.8 | -5.4 | -48.2 | -17.7 |
| Taxes | 49.4 | 52.2 | 91.2 | 122.0 |
| Consolidated profit or loss for the period | -14.2 | -13.0 | -25.7 | -29.1 |
| Adjusted consolidated profit or loss for the period | 35.2 | 39.1 | 65.5 | 92.9 |
| Free cash flow (before M&A transactions) | 38.5 | 46.3 | 78.5 | 104.2 |
| 50.2 | 32.2 | 127.4 | 115.9 |
| Net debt (Sep. 30/Dec. 31) | 860.9 | 718.0 |
